In March, Dr. Reach, who owned three buprenorphine clinics in Virginia and Tennessee, pleaded guilty to three counts of causing drugs to be misbranded while held for sale, according to a June 7 Justice Department news release.
According to the report, he induced various quantities of Schedule III and IV prescription drugs to be dispensed without valid prescriptions by the providers at his clinic. The drugs were prescribed without a legitimate medical purpose and beyond the bounds of professional practice.
He is sentenced to six months to be followed by 18 months of home detention. He was also ordered to forfeit $50,000 and pay a $100,000 fine.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
